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Guanylate cyclase-activating proteins (GCAPs)
are Ca2+-binding proteins myristoylated at the
N terminus that regulate guanylate cyclases in
photoreceptor cells and belong to the family of
neuronal calcium sensors (NCS). Many NCS pro-
teins display a recoverin-like ‘‘calcium-myristoyl
switch’’ whereby the myristoyl group, buried
inside the protein in the Ca2+-free state, be-
comes fully exposed upon Ca2+ binding. Here
we present a 2.0 A˚ resolution crystal structure
of myristoylated GCAP1 with Ca2+ bound. The
acyl group is buried inside Ca2+-bound GCAP1.
This is in sharp contrast to Ca2+-bound recov-
erin, where the myristoyl group is solvent ex-
posed. Furthermore, we provide direct evidence
that the acyl group in GCAP1 remains buried
in the Ca2+-free state and does not undergo
switching. A pronounced kink in the C-terminal
helix and the presence of the myristoyl group
allow clustering of sequence elements crucial
for GCAP1 activity.
INTRODUCTION
The neuronal calcium sensor (NCS) protein family consists
of a group of Ca2+-binding proteins whose expression is
restricted to neuronal systems including retinal photo-
receptor cells (Burgoyne and Weiss, 2001; Haeseleer
et al., 2002; Palczewski et al., 2000; Polans et al., 1996).
These proteins bind Ca2+ through EF-hand motifs and
many of them are fatty acylated at the amino terminus,
most frequently with myristic acid (Ames and Ikura,
2002). NCS proteins serve as switches for Ca2+ signaling
by assuming different conformations upon Ca2+ binding
and dissociation. Two members of this family, recoverin
and guanylate cyclase-activating proteins (GCAPs), play
roles in phototransduction, whereas other family mem-
bers mediate diverse Ca2+-dependent neuronal pro-
cesses such as neurotransmitter release, modulation of
ion channels, and regulation of gene expression (Bur-
goyne, 2007). Despite their sequence similarity, NCS pro-1392 Structure 15, 1392–1402, November 2007 ª2007 Elseviteins possess specialized activities and are typically not
interchangeable (Burgoyne, 2007).
Phototransduction in retinal photoreceptors is modu-
lated by Ca2+ signaling (Palczewski et al., 2000; Polans
et al., 1996). Photon absorption by opsins triggers a signal-
ing cascade that results in hydrolysis of the second mes-
senger cGMP in the cytoplasm. As cellular cGMP levels
drop, cGMP-gated cation channels close and photore-
ceptor cells hyperpolarize, leading to synaptic transmis-
sion of the light signal. Reconstitution of the dark potential
requires activation of photoreceptor guanylate cyclases
(GCs) to replenish the cGMP pool. This process is Ca2+
dependent and mediated by GCAPs. Closing of the
cGMP-gated cation channels occurs and Ca2+ is extruded
from the cytoplasm by the Na+/Ca2+-K+ exchanger, which
lowers free Ca2+ from a dark concentration of500 nM, to
30 nM. Whereas Ca2+-bound GCAPs inhibit photore-
ceptor GCs, a drop in free Ca2+ results in GCAPs losing
their bound Ca2+ and adopting a conformation that acti-
vates photoreceptor GCs and restores the pool of cGMP
(Polans et al., 1996).
Two GCAPs (GCAP1 and GCAP2) first isolated from
bovine retina (Dizhoor et al., 1995; Gorczyca et al., 1995;
Palczewski et al., 1994) are present in all mammals. A third
isoform, GCAP3, is expressed in human and zebrafish
(Danio rerio) retinas (Haeseleer et al., 1999; Imanishi
et al., 2002), and a guanylate cyclase-inhibitory protein
(GCIP) has been identified in frog cones (Li et al., 1998).
At least five additional GCAPs (GCAP4–8) are predicted
to be present in pufferfish (Fugu rubripes) and zebrafish
genomes (Imanishi et al., 2004). These are all amino-termi-
nal acylated proteins with four EF-hand motifs, one of
which, EF-1, is unable to bind Ca2+. In vitro and in vivo,
GCAP1 and GCAP2 regulate both photoreceptor GCs
(GC1 and GC2, also known as GC-E and GC-F) (Baehr
et al., 2007). However, GCAP1 and GCAP3 are primarily
expressed in cones, whereas GCAP2 is prevalent in rods
(reviewed in Dizhoor and Hurley, 1999; Haeseleer et al.,
2002). Autosomal dominant cone dystrophies have been
associated with single point mutations in human GCAP1
(Payne et al., 1998), but no disease-causing mutations
have been identified in either GCAP2 or GCAP3. Specif-
ically, Y99C, I143NT, L151F, and E155G mutations in
GCAP1 have been linked to autosomal dominant cone
dystrophies (for the most recent report, see Sokal et al.,er Ltd All rights reserved
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Crystal Structure of MyrGCAP12005). Each of these mutations leads to altered Ca2+ sen-
sitivity of GCAP1, resulting in incomplete inhibition of GC1
at high Ca2+ concentrations, an abnormally high cGMP
concentration in cone cells, and retinal degeneration. An-
other mutation, P50L, appears to lower the stability of
GCAP1 in association with cone apoptosis (Newbold
et al., 2002).Whereas E155G clearly disables Ca2+ binding
to EF-4 by removing one of the key Ca2+-coordinating side
chains, the molecular mechanisms for the other disabling
mutations are less certain.
Recoverin is probably the best structurally character-
ized protein among the myristoylated NCS (myrNCS)
family. NMR structures of myristoylated recoverin (myr-re-
coverin) in the Ca2+-bound and Ca2+-free states illustrate
its Ca2+-triggered conformational changes (Ames et al.,
1997). The Ca2+-free form of myr-recoverin sequesters
the acyl group in a hydrophobic cleft of its N terminus, ren-
dering the protein soluble in the cytosol. Upon Ca2+ bind-
ing, the myristoyl group is extruded and becomes fully ex-
posed. This process is known as the ‘‘calcium-myristoyl
switch’’ and allows the recruitment of myr-recoverin to
membranes upon Ca2+ binding (Valentine et al., 2003).
Other myrNCS proteins including hippocalcin and neuro-
calcin also function by a similar mechanism (Burgoyne
and Weiss, 2001; O’Callaghan et al., 2002; Spilker et al.,
2000). However, some myrNCS proteins such as NCS-1
and GCAPs do not appear to undergo a canonical cal-
cium-myristoyl switch (Hwang and Koch, 2002; Olshev-
skaya et al., 1997). Whereas membrane localization of
GCAPs does not depend on Ca2+ concentration (Gorc-
zyca et al., 1995), GCAP1myristoylation is required for ap-
propriate regulation of GC1 within the physiological Ca2+
concentration range (Hwang and Koch, 2002; Otto-Bruc
et al., 1997). Thus, the role of themyristoyl group inGCAPs
has been unclear.
Here we present the 2.0 A˚ resolution crystal structure of
myrGCAP1 with Ca2+ bound, to our knowledge the first
crystallographic example of a myrNCS. We show that, in
contrast to recoverin and contrary to earlier reports, the
myristoyl group is completely buried in the Ca2+-bound
state of myrGCAP1. The protein adopts a structure that
buries the acyl group between the N- and C-terminal
helices, which harbor sequences previously identified as
crucial for GCAP1 regulation of photoreceptor GCs.More-
over, we provide direct evidence for the nonswitching
nature of the myristoyl group in GCAPs by showing that
the acyl group remains buried inside the protein upon
Ca2+ dissociation from myrGCAP1. We also present a
plausible molecular mechanism for the effect of the
Y99C mutation in human GCAP1 that is associated with
cone dystrophies.
RESULTS
MyrGCAP1 Structure Overview
We have determined the crystal structure of chicken
myristoylated GCAP1 (myrGCAP1) with Ca2+ bound and
refined it to 2.0 A˚ resolution (refinement statistics are
shown in Table 1). The protein carries a G6S mutation toStructure 15, 1392–14increase the efficiency of myristoylation by a coexpressed
yeastN-myristoyl transferase. EfficientGCAP1myristoyla-
tion was confirmed bymass spectrometry and the purified
protein was fully active in regulating photoreceptor GC
(data not shown). The finalmodel contains all but theC-ter-
minal 14 amino acids that could not be traced, presumably
as a result of conformational flexibility. These residues are
not required for GCAP1 activity, as previously shown by
C-terminal truncation of GCAP1 (Otto-Bruc et al., 1997).
Importantly, very clear electron density allowed the unam-
biguousmodeling of the amino-terminal myristoyl group in
the myrGCAP1 structure.
Our structure of Ca2+-bound myrGCAP1 captures this
protein in the form that inhibits GC. Failure of GCAP1 to
fully inhibit GC1 at high Ca2+ concentration is associated
with cone degeneration (Dizhoor et al., 1998; Sokal
et al., 1998). The four EF-hand motifs are arranged in
two domains in Ca2+-bound myrGCAP1 (Figure 1). EF-1
(residues 17–42) and EF-2 (residues 50–82) form the N-
terminal domain, whereas EF-3 (residues 87–118) and
EF-4 (residues 130–160) are contained in the C-terminal
domain. A short loop between EF-2 and EF-3 links these
domains together. Ca2+ ions are bound to EF-2, EF-3,
and EF-4, whereas EF-1 does not bind Ca2+, as observed
for other GCAPs (Ames et al., 1999; Stephen et al., 2006).
As a consequence, the interhelical angle between the two
helices of EF-1 is 125, significantly larger than the aver-
age 108 observed for the Ca2+-occupied EF-2-4.
The overall structure of myrGCAP1 is quite compact.
The link between the N- and C-terminal domains in myrG-
CAP1 is strengthened by a novel interaction between the
N- and C-terminal helices. The C-terminal helix (green in
Figure 1) is partially unraveled and sharply kinked, and it
interacts in an antiparallel orientation with the N-terminal
helix (red in Figure 1) tying the two domains together.
The Myristoyl Group Is Completely Buried in
Ca2+-Bound MyrGCAP1
The present structure of Ca2+-bound myrGCAP1 is, to our
knowledge, the first example of amyristoylatedGCAP and
the fatty acid is unambiguously observed in the electron
density map (Figure 2A). In sharp contrast to Ca2+-bound
recoverin (see below), the myristoyl group in Ca2+-bound
GCAP1 is completely buried in the core of the N-terminal
domain (Figure 1).
Both EF hands from the N-terminal domain contribute
hydrophobic side chains to form the binding pocket for
the myristoyl group (Figures 1 and 2B). Residues W20,
F38, and F42 are from EF-1 (the non-Ca2+-binding EF),
whereas the Ca2+-bound EF-2 supplies residues V55,
M58, F62, Y75, L79, and V82. The N- and C-terminal heli-
ces play a crucial role in binding the myristoyl group. The
N-terminal helix contributes residues M4, V9, and L12.
Importantly, the C-terminal portion of the kinked C-termi-
nal helix (green in Figures 1 and 2) forms one side of the
myristoyl-binding pocket, contributing the side chains of
residues L174, I177, V178, and I181. These interactions
further strengthen the structural link between the N- and
C-terminal domains of GCAP1.02, November 2007 ª2007 Elsevier Ltd All rights reserved 1393
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Crystal Structure of MyrGCAP1Table 1. Data Collection, Phasing, and Refinement Statistics
Native Yb3+
Data Collection
Space group P41212 P41212
Cell dimensions
a = b (A˚) 73.33 73.49
c (A˚) 73.23 70.98
a = b = g () 90.00 90.00
Peak Inflection Remote
Wavelength 1.5498 1.3856 1.3862 1.3122
Resolution (A˚)a 50–2.0 42–3.4 42–3.4 42–3.4
Rsym
b 5.3 (15.7) 12.4 (38.1) 11.5 (33.0) 11.7 (34.6)
I/sI 22.4 (7.4) 16.1 (4.5) 17.5 (5.2) 17.2 (5.1)
Completeness (%) 96.7 (98.2) 99.1 (99.2) 99.0 (99.6) 98.7 (98.6)
Redundancy 7.0 (6.8) 3.8 (3.7) 3.7 (3.7) 3.8 (3.7)
Phasing
Root-mean-square FH/3
c 1.0 0.7 1.0
FOM before DMd 0.65 (0.51)
FOM after DM 0.83 (0.68)
Refinement
Resolution (A˚) 29.9–2.0
Number of reflections 13,373
Rwork/Rfree
e 21.9/25.1
Number of atoms
Protein 1515
Ligand/ion 3
Water 84
B factors
Protein 26.3
Ligand/ion 17.0
Water 30.2
Rms deviations
Bond lengths (A˚) 0.006
Bond angles () 1.1
a Values in parentheses are for highest-resolution shell: 3.52–3.40 for the MAD data sets; 2.07–2.00 for the native data set.
b Rsym = ShSij(Ii(h)  < I(h) >)j/ShSI Ii(h), where Ii(h) is the Ith measurement of reflection h and < I(h) > is the weighted mean of all
measurements of h. Bijvoet measurements were treated independently for the MAD phasing data sets.
c Rms FH/3 = (1/n
P
FH
2)1/2/(1/n
P
32)1/2, where FH is the structure factor amplitude for anomalous scatterers and 3 is the lack of
closure expression for each wavelength in the MAD data set.
d FOM before DM indicates the figure of merit before density modification.
e Rwork =
PjFobs  Fcalcj/
P
Fobs, where Fobs = observed structure factor amplitude and Fcalc = structure factor calculated from the
model. Rfree is computed in the same manner as Rcryst, using the test set of reflections.GCAP1 is acylated at the N terminus in vivo (primarily
with myristic acid) (Palczewski et al., 1994) and acylation
is required for efficient regulation of photoreceptor GCs
within the physiological range of Ca2+ concentrations.
However, unmyristoylated GCAP1 (unmyrGCAP1) can1394 Structure 15, 1392–1402, November 2007 ª2007 Elsevierregulate GC1 in vitro, albeit with reduced efficiency and al-
tered Ca2+ sensitivity (Hwang and Koch, 2002; Otto-Bruc
et al., 1997). This result suggests that unmyrGCAP1 is at
least partially folded. We obtained far-UV circular dichro-
ism (CD) spectra of myristoylated and unmyristoylatedLtd All rights reserved
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Crystal Structure of MyrGCAP1Figure 1. Structure of MyrGCAP1 with Ca2+ Bound
(A and B) Cartoon representation of myrGCAP1 in front (A) and back (B) views. The N-terminal helix is red, N-terminal domain (EF-1 and EF-2) is
orange, C-terminal domain (EF-3 and EF-4) is yellow, kinked C-terminal helix is green, and the Ca2+ ions andmyristoyl group are shown as dark green
and dark blue space-filling spheres, respectively.
(C and D) Surface representation of myrGCAP1 in front (C) and top (D) views. The surface is semitransparent to reveal the cartoon representation and
the buried myristoyl group.GCAP1 at 25C to evaluate the secondary structure of
these two forms of GCAP1 in the presence of Ca2+ (see
Figure S1 in the Supplemental Data available with this
article online). As expected, nomassive changes in overall
secondary structure content are observed. However,
there is some loss of ellipticity in the unmyristoylated pro-
tein. This change is probably a result of unraveling of the
N- and C-terminal helices when the myristoyl group is
not present to constrain their conformations, consistent
with increased proteolytic accessibility reported previ-
ously (Rudnicka-Nawrot et al., 1998). It is worth noting
that Ca2+-saturated unmyrGCAP1 failed to crystallize de-Structure 15, 1392–140spite extensive trials. This observation also is consistent
with the increased conformational flexibility in GCAP1
when the myristoyl group is absent.
Acyl Packing in MyrGCAP1 and Myr-Recoverin
Thepacking of themyristoyl group in our structure of Ca2+-
bound myrGCAP1 is opposite that observed for the acyl
group in Ca2+-bound recoverin (Figures 3A–3C). The NMR
structure of myr-recoverin shows complete exposure of
the acyl group in the Ca2+-bound state (Ames et al., 1995,
1997), whereas the myristoyl group in Ca2+-bound myrG-
CAP1 is completely buried inside the protein (Figure 1).Figure 2. The Myristoyl Group and Its
Binding Site
(A) Fobs  Fcalc simulated annealing omit map
contoured at the 3s level showing the electron
density for the myristoyl group linked to the N
terminus of GCAP1. The refined model includ-
ing the acyl group is shown for reference.
(B) A series of hydrophobic side chains (green
sticks) lines a deep pocket where the myristoyl
group (red sticks and semitransparent red sur-
face) is sequestered. The secondary structure
elements are shown in faded shades of the
colors assigned in Figure 1.2, November 2007 ª2007 Elsevier Ltd All rights reserved 1395
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Crystal Structure of MyrGCAP1Figure 3. Structural Comparison of
MyrGCAP1 and Myr-Recoverin
(A) Structure superposition (performed with the
program DaliLite; Holm and Park, 2000) of
myrGCAP1 and myr-recoverin in their Ca2+-
bound forms. Coloring of GCAP1 is as shown
in Figure 1. Conserved structural features in re-
coverin are shown in lighter shades of the
GCAP1 colors. The divergent elements in re-
coverin are the myristoyl group (light blue),
the N-terminal helix and loops (magenta), and
the C-terminal helix (cyan). The Ca2+ ions are
omitted for clarity.
(B and C) Structure of GCAP1 (B) and
recoverin (C) oriented as in (A).
(D) Structure superposition (Holm and Park,
2000) of the N-terminal domains of Ca2+-
bound myrGCAP1 and Ca2+-free myr-recov-
erin. Conserved structural features are shown
as ribbons in light orange (GCAP1) and light
yellow (recoverin). The structurally divergent
elements for GCAP1 include, from C terminus to N terminus, the EF-1 helix (orange, labeled GCAP-E1), connecting loop (bright red), N-terminal helix
(magenta, labeled GCAP-H1), and N-terminal loop andmyristoyl group (blue). The corresponding elements in recoverin are colored yellow (EF-1 helix,
labeled Rec-E1), light red (connecting loop), light pink (N-terminal helix, labeled Rec-H1), and light blue (N-terminal loop and myristoyl group).
(E and F) N-terminal domains of GCAP1 (E) and recoverin (F) oriented as in (D).In recoverin, transition to its Ca2+-free conformation is
accompanied by sequestration of the acyl group in a hy-
drophobic cleft of its N-terminal domain that characterizes
the so-called calcium-myristoyl switch (Ames et al., 1997).
Thus, both myr-recoverin and myrGCAP1 are able to bind
the acyl group in a solvent-inaccessible site. However, su-
perposition of the N-terminal domains of Ca2+-bound
GCAP1 and Ca2+-free recoverin shows that these proteins
sequester the acyl group in very different orientations. As
shown in Figures 3D–3F, the structures of the two proteins
diverge at the entering helix to EF-1 (orange rod for
GCAP1, yellow rod for recoverin) that fails to bind Ca2+
in both proteins. The loop (red rod for GCAP1, light-red
rod for recoverin) connecting this EF-1 helix to the N-ter-
minal helix (magenta rod for GCAP1, light-pink rod for re-
coverin) is much shorter in GCAP1 than it is in recoverin.
As a consequence, the N-terminal helices pack against
the N-terminal domains of GCAP1 and recoverin in oppo-
site directions so that the binding orientations for the bur-
ied myristoyl groups are almost perpendicular to one
another. Thus, although a few conserved hydrophobic1396 Structure 15, 1392–1402, November 2007 ª2007 Elsevieresidues participate in acyl binding in both myrGCAP1
and myr-recoverin, the acyl orientation and binding sites
diverge between these two proteins.
MyrGCAP1 Does Not Undergo a Ca2+-Induced
Myristoyl Switch
We tested whether solvent exposure of the acyl group
changes in the Ca2+-free state of GCAP1 with an in vitro
fluorescence-quenching assay.We replaced themyristoyl
group of GCAP1with a fluorescently labeled fatty acid (16-
nitrobenzoxadiazole [NBD]-palmitoyl) using an in vitro
acylation system (Towler et al., 1987) and then monitored
solvent exposure of the acyl group by fluorescence-
quenching methodology. Figure 4 shows that low
millimolar concentrations of Cs+ efficiently quench the
fluorescence emission of free 16-NBD-palmitoyl-CoA. In
contrast, the fluorescent acyl group is largely inaccessible
to the quencher when it is attached to Ca2+-saturated 16-
NBD-palmitoyl-GCAP1, consistent with the buried acyl
group observed in the crystal structure. Moreover, the
fluorescent acyl group attached to GCAP1 remainedFigure 4. Fluorescence Spectroscopy of
16-NBD-Palmitoyl-Labeled GCAP1
(A) Stern-Volmer plots showing fluorescence
quenching of 16-NBD-palmitoyl-GCAP1 and
free 16-NBD-palmitoyl-CoA by CsCl in the
presence or absence of 0.6 mM Ca2+. Fluo-
rescence intensity was determined at the
maximum of emission spectra without (F0) or
with (F) the quencher, after correction for a
blank spectrum.
(B) Fluorescence emission spectra of free 16-
NBD-palmitoyl-CoA and 16-NBD-palmitoyl-
GCAP1 in the presence and absence of Ca2+
(lex = 460 nm).r Ltd All rights reserved
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Crystal Structure of MyrGCAP1Figure 5. Details Surrounding the Kink in
the C-Terminal Helix of GCAP1
(A) The kink in the C-terminal helix and the side
chains important for its stabilization are shown
as sticks. The color scheme is as in Figure 1
and hydrogen bonds are shown as red dotted
lines.
(B) Packing of Y98 (whose mutation to C98 is
linked to retinal disease) among hydrophobic
side chains (shown as sticks) between EF-3
and the kink of the C-terminal helix (in green
sticks).inaccessible to the quencher when the protein was in-
cubated in EGTA to induce its Ca2+-free conformation
(Figure 4A). Similar results were observed using I anion
and acrylamide as quenchers (data not shown). Thus,
these observations indicate that the N-terminal acyl group
in GCAP1 remains buried inside the protein in both the
Ca2+-bound and Ca2+-free states. Furthermore, NBD fluo-
rescence shifted toward shorter wavelengths (from
532 nm for free NBD to 526 nm for NBD-GCAP) when
the fluorophore was attached to the protein, thereby indi-
cating a more hydrophobic environment for the probe
(Figure 4B). Thus, GCAP1 has a nonswitchable myristoyl
group that remains buried inside the protein in both the
Ca2+-bound and Ca2+-free states.
Stabilization of the Kink in the C-Terminal Helix
The C-terminal stretch of polypeptide containing amino
acids 162–184 (shown in green in the figures) adopts a
helical conformation where the central residues (170–
174) are partially unraveled, thereby introducing a sharp
kink in the helix. This kink is required for the most C-termi-
nal part of that helix to contact the N-terminal helix (red in
Figure 1) and the myristoyl group, creating a strong bridge
between the N- and C-terminal domains of GCAP1 (Fig-
ures 1A and 1B). As described below, residue Y98 is
involved in stabilizing the C-terminal helix kink. Impor-
tantly, mutation of this Tyr to Cys in human GCAP1
(Y99C with human protein numbering) renders the protein
unable to fully inhibit GC at a physiologically high free-
Ca2+ concentration (0.5 mM), which in turn leads to
cone degeneration and retinal disease (Payne et al.,
1998). Thus, stabilization of the C-terminal helix kink
appears crucial for the physiological role of GCAP1.
A network of hydrogen-bonding interactions between
the main-chain atoms of the C-terminal helix and the sur-
rounding side chains stabilizes the kinked helix conforma-
tion (Figure 5A). In ideal a helices, the carbonyl groups of
peptide bonds are aligned with the helix axis. In this orien-
tation, the carbonyl from a residue at position n hydrogen
bonds with the amide nitrogen of the residue at position
n + 4. The C-terminal helix of GCAP1 is first unraveled
by stabilizing the carbonyl of L168 (residue n) out of align-
ment with the helix axis through a hydrogen bond with the
side chain of Y98. The amide nitrogen of L172 (the n + 4Structure 15, 1392–140residue) is then hydrogen bonded to the side chain of
Y94. Partial unraveling of the helix is further stabilized by
hydrogen-bonding interactions between the main-chain
carbonyl of S171 with the side chain of R123. The kinked
conformation is stabilized by a hydrogen bond between
the main-chain carbonyl of R170 and the imidazole nitro-
gen of H176, as well as a salt bridge between the side
chains of R170 and E162.
Residue Y98 plays an important role in the stabilization
of the C-terminal helix kink. Y98 is located at the boundary
between the entering helix and the Ca2+-binding loop of
EF-3, and its aromatic ring is tightly packed (Figure 5B).
Moreover, it is sandwiched between two layers of hydro-
phobic residues with I118, Y94, L97, and I114 on one
side and I115, L111, L168, F154, and I106 on the other.
Water molecules appear to be excluded from this site,
as no crystallographic water molecules are visible within
9 A˚ of the Y98 aromatic ring. Hydrophobic interactions
around Y98 are also linked to the Ca2+-bound conforma-
tion of EF-3 (Figure 5B). In a typical EF-hand motif, loop
residues in positions 1, 3, 5, 7, 9, and 12 directly coordi-
nate the Ca2+ ion. Significantly, I106 (one of the hydropho-
bic residues that interact with Y98) occupies position 8 in
the Ca2+-binding loop in EF-3. A Y98C mutation, associ-
ated with retinal disease in humans (Payne et al., 1998),
would destabilize the C-terminal helix kink in two ways,
by (1) abolishing the hydrogen bond between Y98 and
the carbonyl oxygen of L168 (the first residue in the helix
kink), and (2) creating a void volume in the hydrophobic
core of the protein as a result of the much smaller size of
the Cys residue side chain compared to Tyr.
Structural Comparison of MyrGCAP1
and Unacylated GCAPs
Comparisons between the Ca2+-bound structures of myr-
GCAP1 and unmyristoylated GCAP2 (unmyr-GCAP2;
Figure 6A) and unmyristoylated GCAP3 (unmyr-GCAP3;
Figure 6B) highlight the role of the myristoyl group in sta-
bilizing the GCAP1 structure. Although the overall archi-
tecture and conformation of the Ca2+-binding EF hands
are conserved between the myristoylated and unmyris-
toylated proteins, the structure of the N- and C-terminal
helices is severely affected in the unmyristoylated
proteins.2, November 2007 ª2007 Elsevier Ltd All rights reserved 1397
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Crystal Structure of MyrGCAP1Figure 6. Structural Comparison of
MyrGCAP1 and UnmyrGCAPs
(A and B) Structure superposition (performed
with the program DaliLite; Holm and Park,
2000) of the Ca2+-bound forms of (A) myrG-
CAP1 and unmyrGCAP2 (Ames et al., 1999)
and (B) myrGCAP1 and unmyrGCAP3 (Ste-
phen et al., 2006). Coloring of myrGCAP1 is
as shown in Figure 1. Conserved structural fea-
tures in the unmyrGCAPs are shown in lighter
shades of the myrGCAP1 colors. The N- and
C-terminal loop and helices of the unmyrG-
CAPs are magenta and cyan, respectively
(unstructured residues are represented as
a dashed line). Ca2+ ions are omitted for clarity.
(C–E) Individual structures of unmyrGCAP2 (C),
myrGCAP1 (D), and unmyrGCAP3 (E) oriented
as in (A) and (B).In the absence of the acyl group, the C-terminal portion
of the kinked C-terminal helix is severely destabilized in
the NMR structure of unmyrGCAP2 to the extent that
no nuclear Overhauser effect (NOE) peaks could be
assigned for this region, thus preventing its modeling
(Ames et al., 1999) (represented as a cyan dashed line in
Figures 6A and 6C). Additionally, the N-terminal region of
unmyrGCAP2 displays a significant degree of conforma-
tional flexibility in the NMR structure (Ames et al., 1999),
and the N-terminal helix (magenta in Figures 6A and 6C)
is in a conformation that would prevent myristoyl binding
as seen inmyrGCAP1. It is possible that myrGCAP2 packs
its acyl group in a way that differs from myrGCAP1. It
seems more likely, however, that the conformation of the
N-terminal helix observed in the structure of unmyrGCAP2
results from not having the packing constraints imposed
by the N-terminal acyl group buried in a binding site similar
to GCAP1. In this context, it is notable that the hydropho-
bic residues lining the myristoyl-binding site in GCAP1 are
conserved in all GCAPs (Imanishi et al., 2004).
Similar conformational instabilityof theN-andC-terminal
helices was observed in the crystal structure of unmyrG-
CAP3 as evidenced by its superimpositionwithmyrGCAP1
(Figure 6B). The N-terminal helix in unmyrGCAP3 is ex-
tremely flexible, to the point that it could not be modeled
in the crystal structure (Stephen et al., 2006) (shown as
a magenta dashed line in Figures 6B and 6E). Even the
entering helix of EF-1 is poorly defined in the crystal struc-
ture of unmyrGCAP3. In addition, the C-terminal portion of
the kinked C-terminal helix (cyan in Figures 6B and 6E) is
packed against the N-terminal domain in unmyrGCAP3 in
a fashion that would prevent myristoyl binding as seen in
myrGCAP1. Again, the flexibility and conformation of the
N- andC-terminal helices in unmyrGCAP3are likely a result
of the absence of the stabilizing acyl group.
Therefore, the N-terminal acylation of GCAPs observed
physiologically is important to maintaining the structural
integrity of their N- and C-terminal helices. This proposal
is consistent with the observation that unmyristoylated
GCAPs regulate photoreceptor GCs in vitro with reduced
efficiency and altered Ca2+ sensitivity (Hwang and Koch,
2002; Otto-Bruc et al., 1997).1398 Structure 15, 1392–1402, November 2007 ª2007 ElsevieDISCUSSION
GCAPs are members of the NCS protein family of which
recoverin, also myristoylated at the N terminus, is proba-
bly the best structurally characterized (Palczewski et al.,
2000). All of these proteins change their conformations
in response to Ca2+ binding and thereby differentially reg-
ulate their target proteins. The acyl group is buried in the
Ca2+-free form of recoverin, but it is extruded and fully
exposed in the protein’s Ca2+-bound state. This Ca2+-
induced exposure of the acyl group is known as the
‘‘calcium-myristoyl switch,’’ which allows recoverin to be
soluble in the Ca2+-free state and to be recruited to the
membrane in the Ca2+-bound state. Based on the se-
quence similarity between recoverin and GCAPs (54%
for the human proteins) it was assumed that, at least in
the Ca2+-bound state, the acyl group would be exposed
in myrGCAP1. This assumption was supported by 1H-
NMR studies suggesting exposure of the acyl group in
myrGCAP2 (Hughes et al., 1998). However, our crystal
structure demonstrates that, in contrast to recoverin, the
myristoyl group is completely buried in the interior of the
N-terminal domain of Ca2+-bound myrGCAP1. We also
used a direct assay to test the solvent exposure of the
acyl group of GCAP1 in solution. Consistent with the
structure, when the myristoyl group was replaced with
a fluorescent acyl group, the fluorophore was inaccessible
to quenching cesium ions (and other quenchers) and dis-
played emission maxima indicative of a hydrophobic en-
vironment. Importantly, the fluorophore remained inac-
cessible to the solvent and displayed similar spectral
features when the protein was incubated with EGTA to
induce its Ca2+-free state. This result indicates that, in
contrast to recoverin, the myristoyl group in GCAP1 is
not subject to Ca2+-induced switching. The nonswitching
nature of the acyl group was suggested previously for
myrGCAP2 based on a few chemical shift changes in
the myristoyl 1H-NMR spectra of the Ca2+-bound and
Ca2+-free forms of this protein (Hughes et al., 1998). Our
crystal structure of Ca2+-bound myrGCAP1 does not
show solvation of the myristoyl group. Instead, the struc-
tural and fluorescence data indicate that the acyl groupr Ltd All rights reserved
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trations of free Ca2+. Furthermore, previous studies of
GCAP membrane association also indicated the absence
of a canonical, recoverin-like myristoyl switch in GCAPs
(Hwang and Koch, 2002; Olshevskaya et al., 1997).
GCAPs are not recruited to membranes in response to
changes in Ca2+ concentration, but rather remain mem-
brane associated at all Ca2+ concentrations (Gorczyca
et al., 1995; Olshevskaya et al., 1997). Moreover, surface
plasmon resonance data showing no Ca2+ dependence
of the association of GCAPs to immobilized phospholipid
membranes also agree with a nonswitchable model for
myrGCAP1 (Hwang and Koch, 2002).
The NCS family has expanded during evolution such
that five classes (A–E) of NCS proteins have been defined
based on amino acid sequence (Burgoyne et al., 2004).
NCS-1, also known as frequenin, represents class A
NCS proteins and is the earliest evolutionary member of
the NCS family with an ortholog present in yeast (Ames
et al., 2000). NCS-1 is myristoylated at the N terminus
and associated with membranes, but its membrane asso-
ciation is not Ca2+ dependent so NCS-1 is thought to lack
a Ca2+-myristoyl switch. Although no structure of myris-
toylated NCS-1 is yet available, 1H-NMR studies suggest
that its myristoyl group is solvent exposed at all Ca2+ con-
centrations, consistent with its invariant membrane asso-
ciation (Ames et al., 2000). This led to the suggestion that
the capability to sequester the acyl group inside the
protein was acquired later in evolution (O’Callaghan and
Burgoyne, 2004). Class B NCS proteins that include
hippocalcin, neurocalcin, and visinin-like proteins have
orthologs in nematodes and constitute the earliest evolu-
tionary example of proteins that undergo a recoverin-like
Ca2+-myristoyl switch. Recoverin and class B NCS pro-
teins such as neurocalcin share similar structures (Vijay-
Kumar and Kumar, 1999), high overall sequence similarity
(55% for bovine proteins), and conservation of the
hydrophobic residues responsible for myristoyl binding
(Vijay-Kumar and Kumar, 1999). Therefore, class B NCS
proteins are thought to have recoverin-like, myristoyl-
binding pockets (Vijay-Kumar and Kumar, 1999). On the
other hand, GCAPs which make up class D NCS proteins
first identified in fish genomes have diverged in how the
myristoyl group is bound and how they respond to Ca2+
binding and dissociation. Together, these observations
suggest that GCAPs with a nonswitching, permanently
buried myristoyl group were the most recent of the
myrNCS proteins to evolve.
Our structure of Ca2+-bound myrGCAP1 captures the
protein in the form responsible for inhibiting GC. Incom-
plete inhibition of photoreceptor GCs within physiological
free-Ca2+ concentrations leads to increased cellular levels
of cGMP and results in retinal disease. Amino-terminal
acylation of GCAP1 is required for full activity at physiolog-
ical concentrations of Ca2+ (Hwang and Koch, 2002; Otto-
Bruc et al., 1997). The GCAP1 structure shows that the
myristoyl group is a central feature in the hydrophobic
core of the N-terminal domain that, by contacting the C-
terminal portion of the kinked C-terminal helix, helps solid-Structure 15, 1392–14ify the bridge between the N- and C-terminal domains
of GCAP1. In contrast, structures of unmyristoylated
GCAP2 and GCAP3 display conformational instability of
their N- and C-terminal helices. Although no structure of
unmyristoylated GCAP1 is yet available, CD data also
are consistent with the structural instability of the N- and
C-terminal helices in unmyristoylated GCAPs.
The presence of the myristoyl group and the partial un-
raveling and kink of the C-terminal helix allow clustering of
the N-terminal helix and C-terminal residues 175–183,
previously identified as crucial for GCAP1 activity (Krylov
et al., 1999; Li et al., 2001; Otto-Bruc et al., 1997; Palczew-
ski et al., 1994; Schrem et al., 1999). GCAP1 is partially
inactivated by deletion of its first 10 amino acids and com-
pletely inactivated when missing the first 25 residues
(Otto-Bruc et al., 1997) that remove the N-terminal helix
and part of the entering helix of EF-1. Similarly, peptide
inhibition studies have shown that myristoylated N-termi-
nal peptides of GCAP1 can inhibit myrGCAP1-stimulated
photoreceptor GC activity (Palczewski et al., 1994;
Schrem et al., 1999). Frog retinae have GCIP, which is
closely related to GCAP1 and can only inhibit photorecep-
tor GCs. Replacing the first 20 amino acids of GCAP1 with
the corresponding residues from GCIP resulted in a chi-
mera unable to activate photoreceptor GCs at low con-
centrations of free Ca2+. Conversely, replacing the first
55 residues of GCIP with residues 1–46 from GCAP1 pro-
duced a chimera that activated photoreceptor GCs at low
concentrations of Ca2+ and inhibited photoreceptor GCs
at high free-Ca2+ concentrations (Li et al., 2001). There-
fore, the N-terminal region of GCAP1 is crucial for stimula-
tion of photoreceptor GCs at low free concentrations of
Ca2+. Similarly, chimeras prepared between GCAP1 and
recoverin also identified residues 21–27 in the N-terminal
region of GCAP1 as crucial for activation of photoreceptor
GCs, whereas the first 9 residues were also required for
inhibition (Krylov et al., 1999).
The kinked C-terminal helix observed in the GCAP1
structure is also crucial for its activity. Previous work has
shown that C-terminal deletions of the kinked helix (amino
acids 159 through the end) are unable to activate photore-
ceptor GCs at low concentrations of free Ca2+ (Krylov
et al., 1999). C-terminal truncations ending in amino acids
172 or 176 also result in proteins unable to activate GC. In
fact, these truncations suppress photoreceptor GC activ-
ity at low concentrations of Ca2+. Furthermore, a chimera
where the C-terminal helix of GCAP1 was replaced with
the C-terminal region of recoverin was unable to activate
photoreceptor GCs at low concentrations of Ca2+, indicat-
ing that the specific sequence encompassing amino acids
157–182 in GCAP1 is required for photoreceptor GC acti-
vation (Krylov et al., 1999). The most important residues in
this region were further delimited to the stretch of poly-
peptide from R178 through R182. Importantly, the latter
represents the most C-terminal half of the kinked C-termi-
nal helix that packs against the N-terminal helix and
myristoyl group in this structure.
We were unable to model the last 14 residues of
GCAP1. However, a truncation that eliminates these02, November 2007 ª2007 Elsevier Ltd All rights reserved 1399
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GCAP1 did not significantly affect its ability to regulate
photoreceptor GCs (Krylov et al., 1999). Therefore, the
crystallographic model presented here contains all the
regions of GCAP1 important for activity and shows them
clustering together around the myristoyl group.
The partial unraveling and kink in the C-terminal helix is
crucial for packing together the N- and C-terminal regions
important for activity. Secondary structure prediction
programs consistently assign residues 162–182 to a con-
tinuous helix. However, this stretch of polypeptide is par-
tially unraveled and kinked in the middle in myrGCAP1.
This feature is also observable in the structures of unmyr-
istoylated GCAP2 and GCAP3. A network of hydrogen
bonds and hydrophobic interactions stabilizes the confor-
mation of this helix. This structure is required to allow the
most C-terminal portion to contact the N-terminal helix
and the myristoyl group, thereby forming a cluster of
residues important for activity. Mutations altering this kink
stabilization network may affect the position of the most
C-terminal portion of the C-terminal helix and thus impact
GCAP1 activity. We propose that the Y99C mutation in
humanGCAP1 (Y98 in this structure of chickenGCAP1) de-
stabilizes theC-terminal helix kink and results in incomplete
inhibition of photoreceptor GCs at high physiological con-
centrations of Ca2+, causing retinal disease.
The N- and C-terminal helices of GCAP1 are important
for activation or inhibition of photoreceptor GCs in a
Ca2+-dependent manner. The clustering of these helices
and the myristoyl group observed in the structure of Ca2+-
bound GCAP1may be responsible for GCAP1 inhibition of
photoreceptor GCs at high concentrations of Ca2+. It is
tempting to speculate that a transition to the Ca2+-free
state of GCAP1might pull these two helices apart, yielding
the conformation responsible for photoreceptor GC acti-
vation at low concentrations of Ca2+. A change in the rel-
ative orientation between the N- and C-terminal domains
as seen upon Ca2+ dissociation in recoverin would indeed
pull the N- and C-terminal helices apart in Ca2+-free
GCAP1. Moreover, mutations destabilizing the kink in
the C-terminal helix also would enhance dissociation of
the N- and C-terminal helices, thereby favoring photore-
ceptor GC activation. This is the effect of the Y99C muta-
tion in human GCAP1. Critical support for this hypothesis
of photoreceptor GC regulation by GCAP1 awaits elucida-
tion of the structure of Ca2+-free GCAP1 and its com-
plexes with GC.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
See the Supplemental Experimental Procedures.
Crystallization and Structure Determination
Initial crystallization screening for chicken myrGCAP1 was carried out
using TOPAZ 1.96 microfluidic crystallization chips (Fluidigm). Diffrac-
tion-quality crystals were then grown using the hanging-drop vapor-
diffusion method at 16C (protein/precipitant, 1.5 ml/1.5 ml).Well-dif-
fracting crystals were obtained from 0.1 M MES (pH 6.5), 24% PEG
20,000, and 0.4 M KNO3, using a myrGCAP1 protein stock supple-1400 Structure 15, 1392–1402, November 2007 ª2007 Elseviermented with 6 mM BaCl2. The crystals were adapted to a cryoprotect-
ing solution consisting of mother liquor and 25% ethylene glycol and
then flash-frozen in a nitrogen stream at 100K. A data set to 2.0 A˚ res-
olution was collected from these crystals at beamline 8.2.2 of the Ad-
vanced Light Source (ALS). The crystals belong to space group P41212
and contain one molecule per asymmetric unit with cell dimensions
provided in Table 1. Although Ba2+ was present in the crystallization
mix, no peaks were observed in the anomalous difference Patterson
map and therefore could not be used for phasing. Thus, these crystals
are regarded as ‘‘native.’’
Crystals grown in 0.1 M Tris-Cl (pH 8.0) containing 1.8 M ammonium
sulfate were soaked for 4 hr in mother liquor containing 10 mM YbCl3.
The soaked crystals were cryoprotected and flash-frozen as described
above. Their structure was determined by multiwavelength anomalous
dispersion (MAD) techniques using a three-wavelength data set to
3.4 A˚ resolution collected at beamline 8.3.1 of the ALS. These crystals
also belong to space group P41212 and are isomorphous with the
native crystals described above. Three clear peaks were identified in
anomalous difference Patterson maps corresponding to Yb3+ replac-
ing the Ca2+ ions in the EF-hand motifs. The programs SOLVE/RE-
SOLVE (Terwilliger, 2003) were used to determine and improve the
experimental phases. The resulting electron density map was readily
interpretable despite the modest resolution of the data set. Data
collection and phasing statistics are summarized in Table 1. Model
building was performed using the programO (Jones, 1978) and refined
against the native 2.0 A˚ resolution data set using CNS (Bru¨nger et al.,
1998). Final refinement statistics are shown in Table 1.
Expression, Purification, and In Vitro Acylation of GCAP1
Yeast N-myristoyltransferase (NMT1) and tobacco etch virus protease
(TEV), both amino-terminally His tagged, were overexpressed in
BL21(DE3) Escherichia coli (Invitrogen) from pRSET-yNMT1 and
pRK793 (Addgene) (Kapust et al., 2001) plasmids, respectively. Pro-
teins were purified using TALON resin (Clontech). Recombinant
GCAP1 was overexpressed in High Five insect cells infected with ba-
culovirus generated using the Bac-to-Bac system (Invitrogen) from
plasmid pFB-GCAP1-1D4, which was derived from pFastBacHT (Invi-
trogen) and a GCAP1 cDNA clone using standard PCR-based cloning
techniques. The sequence of the GCAP1 expressed is as follows:
MSYYHHHHHHDYDIPTTENLYFQ/GNIMEGK.LAAEAAGTETSQVAPA,
where the underlined residues are the initiation Met, 63His tag, TEV
cleavage site, and 1D4 tag, respectively. The TEV excision site is indi-
cated by a slash and the GCAP1 sequence is italicized. TALON resin
(Clontech) was used to purify GCAP1 from cleared insect cell lysate
obtained by sonication and ultracentrifugation. The protein, eluted in
200 mM imidazole (pH 7.0), 50 mM monosodium phosphate, 300
mM NaCl, and 5% glycerol, was diluted 2-fold with 50 mM HEPES
(pH 7.5) and 5% glycerol and treated with TEV to remove the His
tag. Amino-terminal acylation with 16-NBD-palmitoyl-CoA (Avanti
Lipids) was carried out at 30C for 12 hr in a reactionmixture (1ml) con-
taining 34 mMGCAP1 in diluted imidazole elution buffer, 50mMHEPES
(pH 8.0), 0.46 mMNMT, and 200 mM16-NBD-palmitoyl-CoA. Acylated-
GCAP1 was purified by immunoaffinity chromatography on monoclo-
nal antibody 1D4 Sepharose 4B. The column was equilibrated and
washed (30 bed volumes) with 10 mM HEPES (pH 7.4) and the protein
was elutedwith 50mMHEPES (pH 7.4), 250mMKCl, 50mMNaCl, and
2 mg/ml 1D4 peptide. GCAP1 acylation was essentially complete.
Nonacylated protein was undetectable by SDS-PAGE and only N-ter-
minal acylation was observed bymass spectrometry (data not shown).
Fluorescence Spectroscopy and Cesium Quenching
Steady-state fluorescence emission spectra were obtained between
480 and 600 nmwith an excitationwavelength of 460 nm at 20C. Fluo-
rescence values were corrected for dilution effects and background
emission of the buffer. Cesium chloride at a concentration range of
0.005–0.2 M was used as a quencher to determine the accessibility
of the emissive 16-NBD-palmitoyl group covalently bound to the N
terminus of GCAP1. The Ca2+-free sample mixture contained 0.2 mMLtd All rights reserved
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Crystal Structure of MyrGCAP116-NBD-palmitoyl-GCAP1 in buffer composed of 40 mM HEPES (pH
7.4), 48 mM KCl, 8 mM NaCl, 10 mM MgCl2, and 1.4 mM EGTA. For
measurements at high Ca2+ concentrations, the sample mix was sup-
plemented with 2 mM Ca2+, of which 0.6 mM remained unbound to
EGTA. A solution of 0.2 mM16-NBD-palmitoyl-CoA was used to obtain
the data for free probe.
Supplemental Data
Supplemental Data include one figure and Supplemental Experimental
Procedures and can be found with this article online at http://www.
structure.org/cgi/content/full/15/11/1392/DC1/.
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